Name: Dr. Tapan Kumar Dash Assistant Professor tapandash94@gmail.com ; tapan.dash@niperhyd.ac.in Google Scholar Citations Orcid

ADDRESS, ROOM NO

Department of Regulatory Affairs & Department of Biopharmaceuticals
NIPER Hyderabad
Balanagar, Hyderabad-500037, TS, INDIA

QUALIFICATION: (REVERSE CHRONOLOGICAL ORDER)

• Ph.D. (2017) in Life Sciences: Nano particles for Drug Delivery Application from National Institute of Scinece Education and Research, Bhubaneswa, India
• M. Pharm. (2010) in Pharmaceutics from Anna University, Tiruchirapppali, India

EXPERIENCE

• Assistant Professor, Dec 2025 - Till date at NIPER, Hyderabad, India
• Lead, April 2025 - November 2025 at Fibroheal Woundcare Private Limited, Bengaluru
• Senior Manager, April 2023 - March 2025 at Fibroheal Woundcare Private Limited, Bengaluru
• Research and Development Manager, Jan 2020 - April 2023 at Fibroheal Woundcare Private Limited, Bengaluru
• National Post Doctoral Fellow, Jul 2017 to Jun 2019 at Indian Institute of Science Education and Research, Kolkata.

COURSES HANDLING(PHD/M.PHARM)

• RA 812: Trademarks and Industrial Designs
• MD 615: Regulatory in Medical Devices

PHD STUDENTS/MASTERS STUDENTS

None

AWARDS / HONOURS

• Moon Shot Award in 2025 by Fibroheal Woundcare Private Limited for contribution on Dermal Matrix
• Bunsen Burner Award in 2021 by Fibroheal Woundcare Private Limited for developing in house Silk Protein

RESEARCH AREAS/INTEREST

Polymer Modification, functionalization, Bioengineered materials, Fields: Cancer, Wound healing, Fibrosis, Protein Processing, Hemostat ,Artificial organs, Exosome based therapeutics, Bioengineered cellulose, algal cellulose and proteins for replacement such as silk protein, collagen, albumin etc

FELLOWSHIPS / GRANTS

• BIRAC-SIBRI in the year 2022 for Development of Bacterial Cellulose Based Internal Hemostats
• National Post Doctoral Fellow 2017, SERB,
• Junior/Senior Research Fellow, Department of Atomic Energy, Govt of India.
• Qualified in graduate aptitude test in pharmacy (GPAT) in the year 2010

PUBLICATIONS / BOOK CHAPTERS

1. Tapan K. Dash and V Badireenath Konkimalla. Selection and optimization of nano- formulation of P-glycoprotein inhibitor for reversal of doxorubicin resistance in COLO205 cells. J of Pharmacy and Pharmacology. 2017, 69(7): 834-843. (IF: 2.4)
2. Tapan K. Dash and V Badireenath Konkimalla. Selection of P-Glycoprotein Inhibitor and Formulation of Combinational Nanoformulation Containing Selected Agent Curcumin and DOX for Reversal of Resistance in K562 Cells. Pharmaceutical Research, 2017, 34(8):1741- 1750. (IF: 3.4)
3. Tapan K. Dash and V Badireenath Konkimalla. Comparative Study of Different Nano- Formulations of Curcumin for Reversal of Doxorubicin Resistance in K562R Cells.Pharmaceutical research.2017, 34(2) 279-289. (IF: 3.4)
4. Tapan K. Dash and V Badireenath Konkimalla. Formulation and Optimization of Doxorubicin and Biochanin A Combinational Liposomes for Reversal of Chemoresistance. AAPS PharmSciTech 2017; 18(4):1116-24. (Impact Factor: 2.4)
5. Tapan K Dash and V Badireenath Konkimalla. Nano-formulations for delivery of bio- molecules: focus on liposomal variants for siRNA delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems 2013, 30 (6). (Impact Factor: 3.3)
6. Tapan K. Dash and V Badireenath Konkimalla. Polymeric modification and its implication in drug delivery: Poly-e-caprolactone (PCL) as a model polymer. Molecular Pharmaceutics, 2012, 9 (9), 2365-2379. (Impact Factor: 4.5)
7. Tapan K. Dash and V Badireenath Konkimalla. Poly-?-caprolactone based formulations for drug delivery and tissue engineering: A review. Journal of Controlled Release, 2012, 158 (1), 15-33. (5th Most cited article of the journal for the period of 2015-2017) (Impact Factor: 10.8)
8. AT Dharmaraja, Tapan K. Dash, V Badireenath Konkimalla, H Chakrapani. Synthesis, thiol-mediated reactive oxygen species generation profiles and anti-proliferative activities of 2, 3-epoxy-1, 4-naphthoquinones. Med Chem Comm 2012, 3 (2), 219-224. (Impact Factor: 2.4)
9. Sushma Indrakumar, Tapan Kumar Dash, Vivek Mishra, Bharat Tandon, and Kaushik Chatterjee. Silk Fibroin and Its Nanocomposites for Wound Care: A Comprehensive Review. ACS Polymers Au DOI: 10.1021/acspolymersau.3c00050
10. Sushma Indrakumar, Akshat Joshi, Tapan K Dash, Vivek Mishra, Bharat Tandon, et al. Silk Composite-based Multifunctional Pellets for Controlled Drug Release toward Advanced Wound Care. ChemRxiv. 2024; doi:10.26434/chemrxiv-2024-wdm73
11. Sushma Indrakumar, Akshat Joshi, Tapan Kumar Dash, Vivek Mishra, Bharat Tandon, Kaushik Chatterjee. Photopolymerized silk fibroin gel for advanced burn wound care, International Journal of Biological Macromolecules, 233, 2023,123569. (IF: 8.2)
12. Sushma Indrakumar, Santanu Ghosh, Tapan Kumar Dash, Vivek Mishra, Bharat Tandon, Kaushik Chatterjee. Silk composite interfacial layer eliminates rebleeding with chitosan- based hemostats, Carbohydrate Polymers, 304,2023,12047. (IF: 11.2)
13. Diptendu Patra, Pawan Kumar, Tapan Kumar Dash, Ipsita Chakraborty, Rangeet Bhattacharyya, and Raja Shunmugam. Gadolinium (III) Coordinated Theranostic Polymer for Proficient Sequential Targeting – Combinational Chemotherapy and T1 Weighted Magnetic Resonance Imaging. ACS Applied Polymer Materials 2022 4 (3), 1752-1763. (IF: 5.0)
14. Saikat Mukherjee, Diptendu Patra, Tapan K Dash, Ipsita Chakraborty, RangeetBhattacharyya, Shantibhusan Senapati, Raja Shunmugam. Dual Imageable PolymerAnchored Platinum Prodrug for Site-specific Cancer Therapy. Polym. Chem., 2019,10, 3066-3078. (IF: 5.3)
15. L Kathawate, PV Joshi, Tapan K. Dash, S Pal et al. Reaction between lawsone and aminophenol derivatives: Synthesis, characterization, molecular structures and anti- proliferative activity. Journal of Molecular Structure 2014 1075, 397-405. (Impact Factor: 2.0)
16. Pawan Kumar, Pintu Kanjilal, Rituparna Das, Tapan K. Dash, Manikandan Mohanan, Trong-Nghia Le, N. Vijayakameswara Rao, Balaram Mukhopadhyay, Raja Shunmugam. 1,6- heptadiynes based cyclopolymerization functionalized with mannose by post polymer modification for protein interaction, Carbohydrate Research, 508, 2021,108397. (IF: 3.1)
17. Tapan Kumar Dash, Diptendu Patra, Parvathy Venu, Biswajit Das, Rangeet Bhattacharyya, and Raja Shunmugam. Hetero-Trifunctional Malonate-Based Nanotheranostic System for Targeted Breast Cancer Therapy ACS Applied Bio Materials 2021, 4 (6), 5251-5265. (IF: 4.7) Publications and Patents.
18. Diptendu Patra, Saikat Mukherjee, Ipsita Chakraborty, Tapan K. Dash, Shantibhusan Senapati, Rangeet Bhattacharyya, and Raja Shunmugam. Iron (III) Coordinated Polymeric Nano-material: A Next Generation Theranostic Agent for High Resolution T1 weightedMagnetic Resonance Imaging and Anticancer Drug Delivery. ACS Biomaterials Science andEngineering. 2018 4 (5): 1738-1749. (IF: 4.4)
19. Sushma Indrakumar, Alaka T. Panicker, Sampath Parasuram, Akshat Joshi, Tapan Kumar Dash, Vivek Mishra, Bharat Tandon, Kaushik Chatterjee. 3D-printed ultra-stretchable silk fibroin-based biocompatible hydrogels. Bioprinting, 36,2023. (CS: 9.1)

Book Chapters:

1. Book chapter: Modification of Cyclodextrin for Improvement of Complexation and Formulation Properties (205 – 224). by TK Dash, VB Konkimalla. in Edited by Vijay Kumar Thakur and Manju Kumari Thakur, Handbook of Polymers for Pharmaceutical Technologies. 2015. Scrivener Publishing LLC.
2. Manjunath B.S., Bharat Tandon, Shakthi Prakash M.R., Vivek Mishra, Tapan Kumar Dash, Circular economy in silk industry, Editor(s): Sabu Thomas, Sneha Sabu Mathew, Hanna J. Maria, Rangam Rajkhowa, In The Textile Institute Book Series, Science and Technology of Silkworm Sericin, Elsevier, 2025, Pages 591-609, ISBN 9780443217364.

Please Click here to see the full list.

PATENTS

1. LAYERED COMPOSITION AND IMPLEMENTATIONS THEREOF. [No. 202141025757]
2. METHOD OF FABRICATING A HYDROGEL WOUND DRESSING MATERIAL AND IMPLEMENTATIONS THEREOF [No. 202241067430]
3. MULTIFUNCTIONAL PELLETS FOR DRUGDELIVERY IN CHRONIC WOUNDS, KITS AND METHODS THEREOF [No. 202341045930]
4. NANODISPERSION OF SILK FIBROIN AND METHOD THEREOF [No. 202341068960]

INVITED TALKS

SPONSORED PROJECTS

Laboratory facilities developed for research / teaching.

None

ADDITIONAL RESPONSIBILITIES

None

ANY OTHER INFORMATION

None